RE:AGM When I read the NR I felt there was quite a bit of unfounded exhuberance wrt "crossing the finish line" comment and I was surprised to hear that they were able to complete the first arm of the study. I thought they had to recruit the patients first then randomize them. Now I'm curious when the first arm of the study was started and completed. It seems that had to be innovative and run through hoops to get it done. As Gilles noted, kudos to those involved to get it going.
So as preliminary hints on how the BG pill or Y-BG Covid study progresses, any leakage of info should make it's way to higher trading volumes / share price, or even perhaps insider buys just based on forward movement of the studies.
boazklinghorn wrote: It was an interesting factoid that the low dose arm of the BG study is already completed so somebody knows something about efficacy. I will be interesting to see if they can keep a lid on this information for the next 4 or 5 months.